Central Nervous System International Prognostic Index (CNS-IPI)
The CNS‑IPI estimates the risk of secondary CNS relapse in DLBCL using the five IPI factors plus kidney/adrenal involvement 1.
Indicaciones de Uso
Used to identify DLBCL patients at elevated risk of CNS relapse and guide need for CNS prophylaxis or baseline CNS staging. High‑risk score (4–6) predicts ~10–12% 2‑year CNS relapse risk 1 [Level I evidence]. Recommended when evaluating patients for CNS prophylaxis per ESMO guidance 2 [Level I evidence]. Highest utility is ruling out low‑risk patients and flagging those needing CNS-directed evaluation.
Información y Precauciones
Identifies DLBCL patients at highest CNS‑relapse risk using age, LDH, stage, ECOG, extranodal sites, and kidney/adrenal involvement; high‑risk scores carry ~10–12% 2‑year relapse risk 1 [Level I evidence]. Useful for excluding low‑risk patients from unnecessary prophylaxis, but has low positive predictive value and misses events in low‑intermediate groups 2 [Level II evidence]. Underperforms when molecular (ABC/unclassified) features drive risk 3 [Level II evidence].